Your session is about to expire
← Back to Search
Rapid Diagnostic Assay for Gonorrhea
Study Summary
This trial will test two methods of rapid diagnosis for urethritis & cervicitis in a clinic setting. 100 patients will be tested to compare the methods.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You do not have symptoms that match urethritis or cervicitis.You have been in close contact with someone who has gonorrhea or chlamydia.You have symptoms in a place other than the genitals at the same time.You have symptoms of a sudden infection in your urethra or cervix.You are suspected or confirmed to have Monkeypox.You have had contact with someone who has gonorrhea or chlamydia.
- Group 1: Standard of Care
- Group 2: Rapid STI Test
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment still available for this experiment?
"Confirmed. According to information provided on clinicaltrials.gov, the current recruitment phase for this medical trial began on March 1st 2023 and was last modified March 22nd 2023. The study is seeking a total of 100 patients from one particular site."
What is the maximum capacity of individuals participating in this medical experiment?
"Affirmative, there is evidence on clinicaltrials.gov that this investigation is seeking to fill participant positions. This research effort was first published on March 1st 2023 and last amended on the 22nd of the same month. The study needs 100 volunteers from a single medical centre."
Share this study with friends
Copy Link
Messenger